Skip to main content
. 2021 Oct 26;16(3):240–251. doi: 10.5469/neuroint.2021.00437

Table 3.

DAP, AK, fluroscopy time regarding aneurysm treatment

Variable Mean DAP (Gy·cm2) AK (mGy) FT (min)
Sex
 Male (n=99) 168.9±117 2,935±2,401 46.3±31.3
 Female (n=228) 137.8±91 2,464±2,142 45.5±32.7
 P-value 0.019* 0.112 0.857
Aneurysm location
 Anterior (n=279) 148.9±94.1 2,568±2,034 45.6±31.5
 Posterior (n=48) 163.6±111.4 2,938±2,507 47.0±25.6
 P-value 0.329 0.263 0.768
Procedural complication
 Without (n=313) 144±86 2,487±1,811 43.3±25.0
 With (n=14) 309±168 5,655±4,758 102.9±70.4
 P-value 0.03* 0.027* 0.007*
Endovascular technique
 Simple (S) (n=159) 143.3±94.8 2,323±1,721 42.1±27.4
 Assisted (A) (n=157) 160.7±99.7 2,994±2,448 50.6±33.9
 FlowDiverter (F) (n=11) 125.5±72.1 1,652±522 30.8±11.3
 P-value S vs. A: P=0.243 S vs. A: P=0.012* S vs. A: P=0.035*
S vs. F: P=0.826 S vs. F: P=0.056 S vs. F: P=0.459
A vs. F: P=0.472 A vs. F: P=0.099 A vs. F: P=0.093

Mean value were calculated using t-test and are shown ad mean±standard deviaton.

DAP, dose-area product; AK, air-kerma; FT, fluoroscopic time.

*

Remained significant.